USA - NASDAQ:SLP - US8292141053 - Common Stock
The current stock price of SLP is 15.4 USD. In the past month the price increased by 0.98%. In the past year, price decreased by -54.9%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 38.08 | 46.51B | ||
DOCS | DOXIMITY INC-CLASS A | 45.35 | 12.66B | ||
WAY | WAYSTAR HOLDING CORP | 33.32 | 7.06B | ||
HTFL | HEARTFLOW INC | N/A | 2.82B | ||
CERT | CERTARA INC | 24.43 | 1.92B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.51B | ||
SDGR | SCHRODINGER INC | N/A | 1.42B | ||
PHR | PHREESIA INC | N/A | 1.34B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 10.94 | 1.33B | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
CTEV | CLARITEV CORP | N/A | 910.13M | ||
CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 898.45M |
Simulations Plus, Inc. engages in the provision of software and consulting services supporting drug discovery, development, research, clinical trial operations, regulatory submissions, and commercialization. The company is headquartered in Research Triangle Park, North Carolina and currently employs 243 full-time employees. The company operates through two segments: software and services. The Company’s business units include cheminformatics, physiologically based pharmacokinetics, clinical pharmacology and pharmacometrics, quantitative systems pharmacology, adaptive learning & insights and medical communications. The firm operates in biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry. The company delivers simulation-enabled performance and intelligence solutions alongside medical communications support for clinical and commercial drug development. Its cutting-edge technology is licensed and utilized by pharmaceutical, biotechnology, and regulatory agencies worldwide.
SIMULATIONS PLUS INC
800 Park Offices Drive, Suite 401
RESEARCH TRIANGLE PARK NORTH CAROLINA 93534 US
CEO: Shawn O'Connor
Employees: 243
Phone: 16617237723
The current stock price of SLP is 15.4 USD. The price decreased by -3.87% in the last trading session.
The exchange symbol of SIMULATIONS PLUS INC is SLP and it is listed on the Nasdaq exchange.
SLP stock is listed on the Nasdaq exchange.
11 analysts have analysed SLP and the average price target is 25.84 USD. This implies a price increase of 67.79% is expected in the next year compared to the current price of 15.4. Check the SIMULATIONS PLUS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
SIMULATIONS PLUS INC (SLP) has a market capitalization of 310.00M USD. This makes SLP a Small Cap stock.
SIMULATIONS PLUS INC (SLP) currently has 243 employees.
SIMULATIONS PLUS INC (SLP) has a support level at 15.06 and a resistance level at 15.77. Check the full technical report for a detailed analysis of SLP support and resistance levels.
The Revenue of SIMULATIONS PLUS INC (SLP) is expected to grow by 10.04% in the next year. Check the estimates tab for more information on the SLP EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SIMULATIONS PLUS INC (SLP) has a dividend yield of 0.61%. The yearly dividend amount is currently 0.24. Check the full fundamental report for a detailed analysis of SLP dividend history, reliability and sustainability.
SIMULATIONS PLUS INC (SLP) will report earnings on 2025-10-22, after the market close.
The PE ratio for SIMULATIONS PLUS INC (SLP) is 23.69. This is based on the reported non-GAAP earnings per share of 0.65 and the current share price of 15.4 USD. Check the full fundamental report for a full analysis of the valuation metrics for SLP.
The outstanding short interest for SIMULATIONS PLUS INC (SLP) is 9.99% of its float. Check the ownership tab for more information on the SLP short interest.
ChartMill assigns a technical rating of 3 / 10 to SLP. When comparing the yearly performance of all stocks, SLP is a bad performer in the overall market: 84.24% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to SLP. SLP has an excellent financial health rating, but there are some minor concerns on its profitability.
Over the last trailing twelve months SLP reported a non-GAAP Earnings per Share(EPS) of 0.65. The EPS increased by 38.3% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -47.03% | ||
ROE | -51.05% | ||
Debt/Equity | 0 |
11 analysts have analysed SLP and the average price target is 25.84 USD. This implies a price increase of 67.79% is expected in the next year compared to the current price of 15.4.
For the next year, analysts expect an EPS growth of -567.9% and a revenue growth 10.04% for SLP